By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Otsuka Pharmaceuticals UK Ltd 

Commonwealth House
2 Chalkhill Road
Hammersmith  London  W6 8DW  United Kingdom
Phone: 44-20-8600-6770 Fax: 44-20-8600-6794



Company News
Sosei Co., Ltd. In-License Urology Drug From Otsuka Pharmaceutical Co., Ltd.10/19/2005 5:12:48 PM
Otsuka Pharmaceutical Co., Ltd. , Galenea Conclude Collaborate Research And Licensing Agreement10/19/2005 5:12:45 PM
Galenea Signs Collaboration And License Agreement With Otsuka Pharmaceutical Co., Ltd.10/19/2005 5:12:44 PM
Otsuka Pharmaceutical Co., Ltd. Grants Exclusive Rights To Develop And Market Rebamipide To Novartis Pharma AG (NVS)10/19/2005 5:12:39 PM
Novartis Pharma AG (NVS) Obtains Rights From Otsuka Pharmaceutical Co., Ltd. To Develop New Treatment For Dry Eye10/19/2005 5:12:38 PM
Otsuka And Prasco Laboratories Sign A Commercial Supply Agreement For PLETAL Tablets10/19/2005 5:11:51 PM
Bristol-Myers Squibb Company (BMY) And Otsuka Pharmaceutical Co., Ltd. Release: ABILIFY(R) (aripiprazole) Approved For Marketing In Europe For The Treatment Of Schizophrenia10/19/2005 5:11:37 PM
Otsuka Pharmaceuticals UK Ltd Selects Britannia Pharmaceuticals Limited To Distribute Adacolumn In The United Kingdom; Novel Treatment For Inflammatory Related Diseases Provides A Significant Alternative To Other Pharmaceutical Therapies10/19/2005 5:10:55 PM
Otsuka Pharmaceutical Co., Ltd.'s Antipsychotic Medication Approved For Marketing In Europe10/19/2005 5:08:42 PM